Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 7/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 3/20 | 1.00 |
| ▸ | TP53 | P04637 | 2/20 | 1.00 |
| ▸ | SRC | P12931 | 2/20 | 0.84 |
| ▸ | APP | P05067 | 8/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.65 |
| ▸ | TTR | P02766 | 6/20 | 0.65 |
| ▸ | MAPT | P10636 | 5/20 | 0.65 |
| ▸ | HPGD | P15428 | 4/20 | 0.65 |
| ▸ | AKR1B1 | P15121 | 4/20 | 0.65 |
| ▸ | POLB | P06746 | 3/20 | 0.65 |
| ▸ | GAA | P10253 | 3/20 | 0.65 |
| ▸ | RECQL | P46063 | 2/20 | 0.65 |
| ▸ | MMP1 | P03956 | 2/20 | 0.65 |
| ▸ | THRB | P10828 | 2/20 | 0.65 |
| ▸ | APEX1 | P27695 | 2/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.65 |
| ▸ | LCK | P06239 | 2/20 | 0.65 |
| ▸ | FYN | P06241 | 2/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chicoric Acid SCHEMBL13772650 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Chicoric Acid SCHEMBL30518333 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Chicoric Acid SCHEMBL964775 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Cichoric Acid SCHEMBL29349701 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Chicoric Acid SCHEMBL30995918 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Chicoric Acid SCHEMBL730803 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Cichoric Acid SCHEMBL29385936 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Chicoric Acid SCHEMBL963407 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Chicoric Acid SCHEMBL21176639 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Cichoric Acid SCHEMBL15532218 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | claimed |
| US-11701400-B2 | Steviol glycoside compositions with reduced surface tension | CARGILL, INCORPORATED (US) | 2023-07-18 | — | — | US | claimed |
| US-20210298243-A1 | UV-B INDUCED PLANT PATHOGEN RESISTANCE | BIOLUMIC LIMITED (NZ) | 2021-09-30 | — | — | US | claimed |
| EP-3876697-A2 | UV-B INDUCED PLANT PATHOGEN RESISTANCE | Biolumic Limited (NZ) | 2021-09-15 | — | — | EP | claimed |
| CN-113271764-A | UV-B induced resistance to plant pathogens | 拜欧卢米克有限公司 | 2021-08-17 | — | — | CN | claimed |
| US-20200260767-A1 | READILY DISSOLVABLE STEVIOL GLYCOSIDE COMPOSITIONS | CARGILL, INCORPORATED (US) | 2020-08-20 | — | — | US | claimed |
| EP-3691468-A1 | READILY DISSOLVABLE STEVIOL GLYCOSIDE COMPOSITIONS | Cargill, Incorporated (US) | 2020-08-12 | — | — | EP | claimed |
| EP-3691466-A1 | STEVIOL GLYCOSIDE COMPOSITIONS WITH REDUCED SURFACE TENSION | Cargill, Incorporated (US) | 2020-08-12 | — | — | EP | claimed |
| CN-111315234-A | Easily soluble steviol glycoside compositions | 嘉吉公司 | 2020-06-19 | — | — | CN | claimed |
| CN-111295097-A | Steviol glycoside compositions with reduced surface tension | 嘉吉公司 | 2020-06-16 | — | — | CN | claimed |
| US-6946490-B2 | Antimicrobial treatment for herpes simplex virus and other infectious diseases | MCGINLEY PARTNERS, LLC (US) | 2005-09-20 | — | — | US | claimed |
| US-20050026902-A1 | Methods and compositions for the treatment or prevention of human immunodeficiency virus and related conditions using cyclooxygenase-2 selective inhibitors and antiviral agents | PHARMACIA CORPORATION | 2005-02-03 | — | — | US | claimed |
| EP-0918458-A4 | ANTIMICROBIAL TREATMENT FOR HERPES SIMPLEX VIRUS AND OTHER INFECTIOUS DISEASES | SQUIRES MERYL (US) | 2004-01-02 | — | — | EP | claimed |
| US-20030104082-A1 | Antimicrobial prevention and treatment of human immunedeficience virus and other infectious diseases | MCGINLEY PARTNERS, LLC (US) | 2003-06-05 | — | — | US | claimed |
| US-20030099726-A1 | Antimicrobial treatment for herpes simplex virus and other infectious diseases | MCGINLEY PARTNERS, LLC (US) | 2003-05-29 | — | — | US | claimed |
| US-20020187207-A1 | Method for extracting, fractionating and purifying polyphenolic compounds originating from fresh plant sorting deviations using a high adsorption and elution performance resin | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE INRA | 2002-12-12 | — | — | US | claimed |
| US-6355684-B1 | AQUEOUS BENZALKONIUM CHLORIDE, ECHINACEA AND ANTIMICROBIAL ISOLATES; VIRICIDES FOR PAPILLOMA, VARICELLA-ZOSTER, AND CYTOMEGALO VIRUSE; HIGH SPEED ANALGESIC; HEALING OF LESIONS; TOPICAL ADMINISTERING | Squires, Meryl J. | 2002-03-12 | — | — | US | claimed |
| US-6350784-B1 | PHYTOCHEMICALS, SURFACTANT, FOLIC ACID, | Squires, Meryl J. | 2002-02-26 | — | — | US | claimed |
| EP-0918458-A1 | ANTIMICROBIAL TREATMENT FOR HERPES SIMPLEX VIRUS AND OTHER INFECTIOUS DISEASES | Squires, Meryl (US) | 1999-06-02 | — | — | EP | claimed |
| WO-1998011778-A1 | ANTIMICROBIAL TREATMENT FOR HERPES SIMPLEX VIRUS AND OTHER INFECTIOUS DISEASES | SQUIRES MERYL (US) | 1998-03-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030099726-A1 | Antimicrobial treatment for herpes simplex virus and other infectious diseases | KCNJ11, KCNJ1, TRPA1 | HSD17B10 2936/4885TDP1 3883/4885ALOX15 2782/4885 |
| US-11701400-B2 | Steviol glycoside compositions with reduced surface tension | STT3A, SIGLEC7, STT3B | HSD17B10 473/4885TDP1 1789/4885ALOX15 4388/4885 |
| US-20020187207-A1 | Method for extracting, fractionating and purifying polyphenolic compounds originating from fresh plant sorting deviations using a high adsorption and elution performance resin | BROX, HPD, VPS28 | HSD17B10 2469/4885TDP1 2564/4885ALOX15 3203/4885 |
| US-20030104082-A1 | Antimicrobial prevention and treatment of human immunedeficience virus and other infectious diseases | CD14, CD59, SLC19A1 | HSD17B10 3387/4885TDP1 4355/4885ALOX15 1638/4885 |
| US-20050026902-A1 | Methods and compositions for the treatment or prevention of human immunodeficiency virus and related conditions using cyclooxygenase-2 selective inhibitors and antiviral agents | PTGS2, PTGS1, PTGES2 | HSD17B10 314/4885TDP1 1351/4885ALOX15 50/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.